Pavan Patel

Stock Analyst at B of A Securities

(0.26)
# 4,418
Out of 5,130 analysts
1
Total ratings
n/a
Success rate
-8.31%
Average return

Stocks Rated by Pavan Patel

Supernus Pharmaceuticals
Oct 29, 2025
Initiates: Buy
Price Target: $65
Current: $51.16
Upside: +27.05%